Quarterly report pursuant to Section 13 or 15(d)

Consolidated Statements Of Cash Flows

v2.4.0.8
Consolidated Statements Of Cash Flows (USD $)
In Thousands, unless otherwise specified
 9 Months Ended
Sep. 30, 2014
Sep. 30, 2013
Cash flows from operating activities attributable to continuing operations:    
Net income $ 104,653 $ 116,876
Adjustments to reconcile income from continuing operations to net cash provided by operating activities attributable to continuing operations:    
Depreciation and amortization 32,714 30,305
Stock-based compensation expense 11,691 10,279
Amortization of debt issuance costs 830 847
Deferred income taxes (2,875) 8,412
Bad debt expense 14,987 15,001
Excess tax benefits from stock-based awards (6,294) (7,754)
Other 115 1,069
Changes in current assets and liabilities:    
Accounts receivable 34,556 41,745
Inventories (150,261) (52,208)
Prepaid expenses and other assets (9,825) (12,725)
Accounts payable, accrued expenses and other current liabilities (2,083) (56,698)
Net cash provided by operating activities attributable to continuing operations 28,208 95,149
Cash flows from investing activities attributable to continuing operations:    
Capital expenditures (24,975) (34,088)
Other (448) 0
Net cash used in investing activities attributable to continuing operations (25,423) (34,088)
Cash flows from financing activities attributable to continuing operations:    
Repayment of long-term debt (9,375) (6,250)
Repurchase of common stock (55,467) (137,025)
Cash dividends paid (39,488) (29,046)
Proceeds from issuance of common stock 2,093 5,886
Tax withholdings related to stock-based awards (10,191) (13,897)
Excess tax benefits from stock-based awards 6,294 7,754
Payment of contingent consideration obligation 0 (2,172)
Net cash used in financing activities attributable to continuing operations (106,134) (174,750)
Total cash used in continuing operations (103,349) (113,689)
Total cash used in discontinued operations (21) (152)
Net decrease in cash and cash equivalents (103,370) (113,841)
Cash and cash equivalents at beginning of period 196,433 222,092
Cash and cash equivalents at end of period 93,063 108,251
Capital expenditures incurred but paid in advance $ 9,100 $ 0